StockTipsArenaBeta

BUY Syngene International Limited — IDBI Capital

BUYSyngene International Limited
Syngene International share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))3 Nov 2026via IDBI Capital Research Calls Telegram

Entry₹417Stated
Target₹445
Total upside +6.71%
Stop loss₹403-3.36% risk
CMP₹417.31d ago
Active+0.07%+6.64%upside left 10d left
Follow IDBI Capital for new calls(29% target hit, 425 closed calls)Get alertsWatch SYNGENE for new buy/sell callsGet alertsSee 203 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:25 pm IST
2 supporting3 neutral1 opposing
Supports the BUY call (2)

MACD above its signal line — bullish momentum

Technicals · macd·7 Nov · today

Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?

NewsLivemint·28 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (3)

Syngene International reported Q2 FY27 financial results with revenue of Rs 833 crore, a 13% sequential growth, and PAT of Rs 32 crore. The filing also notes the departure of CFO Deepak Jain.

BSE · Company Update·27 Oct · 1w ago

(opens in new tab)

Syngene International reported unaudited financial results for the quarter and half year ended September 30, 2026, including consolidated and standalone financial statements.

BSE · Board Meeting·27 Oct · 1w ago

(opens in new tab)

Syngene International Limited reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

NSE · Outcome of Board Meeting·27 Oct · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses

NewsCnbc-Tv18·27 Oct · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Syngene International

All analyst calls on Syngene International

More from IDBI Capital

Every call and its outcome